Date published: 2026-5-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

C. trachomatis Inhibitors

The chemical class denoted as C. trachomatis Inhibitors constitutes a multifaceted assembly of organic compounds that have been meticulously designed and engineered to thwart the vital processes essential for the propagation and reproduction of the bacterium Chlamydia trachomatis. This category encompasses a broad spectrum of molecular structures, each strategically fashioned to interact with specific biological targets within the intricate landscape of Chlamydia trachomatis. These inhibitors operate at a minute level, engaging in intricate molecular dialogues aimed at perturbing the intricate biochemical choreography upon which the bacterium's sustenance within host cells relies. Within the domain of C. trachomatis Inhibitors, researchers have forged an extensive array of chemical frameworks, each tailored to interface with distinct biomolecular ensembles that are pivotal to the bacterium's life cycle. The modus operandi of these inhibitors hinges upon their ability to form intricate interactions with key macromolecules and pathways that Chlamydia trachomatis exploits for its survival. These interactions can disrupt enzymatic activities, attenuate essential cellular signaling cascades, and interfere with critical structural components, collectively culminating in a cascade of disruptions that challenge the bacterium's capacity to perpetuate itself.

The complexity of Chlamydia trachomatis infections necessitates a sophisticated arsenal of chemical strategies. Researchers delve into the molecular landscapes of bacterial-host interactions, unraveling the intimate interplay between pathogen and host. In doing so, they identify exploitable vulnerabilities within Chlamydia trachomatis's intricate molecular repertoire, serving as potential footholds for inhibitory interactions. This investigative pursuit has resulted in the discovery of diverse chemical scaffolds, each uniquely attuned to a specific facet of the bacterium's lifecycle. As such, the C. trachomatis Inhibitors chemical class stands as a testament to the ingenuity of contemporary chemical design, as it endeavors to unlock the secrets of microbial pathogenesis and pioneer novel approaches to impede the progression of Chlamydia trachomatis infections.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Azithromycin

83905-01-5sc-254949
sc-254949A
sc-254949B
sc-254949C
sc-254949D
25 mg
50 mg
500 mg
1 g
5 g
$52.00
$103.00
$260.00
$364.00
$728.00
17
(1)

Macrolides are a class of antibiotics that inhibit bacterial protein synthesis. Azithromycin is commonly used for Chlamydia infections by binding to the bacterial ribosome and preventing protein production.

Levofloxacin

100986-85-4sc-252953
sc-252953B
sc-252953A
10 mg
250 mg
1 g
$40.00
$46.00
$54.00
3
(1)

Fluoroquinolones interfere with bacterial DNA replication and repair. Levofloxacin is effective against Chlamydia by inhibiting DNA gyrase and topoisomerase IV, enzymes essential for DNA processing.

Doxycycline-d6

564-25-0 unlabeledsc-218274
1 mg
$16500.00
(0)

Tetracyclines inhibit protein synthesis in bacteria by binding to the bacterial ribosome. Doxycycline is used for Chlamydia infections and disrupts bacterial growth.

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$63.00
$110.00
$214.00
1
(1)

Nucleoside analogues mimic the building blocks of DNA and RNA. Ribavirin is an antiviral drug that inhibits Chlamydia replication by interfering with nucleic acid synthesis.

Ceftriaxone, Disodium Salt, Hemiheptahydrate

104376-79-6sc-211050
sc-211050A
1 g
5 g
$179.00
$449.00
1
(1)

Cephalosporins are beta-lactam antibiotics that inhibit bacterial cell wall synthesis. Although more commonly used for bacterial infections like gonorrhea, ceftriaxone might have some activity against Chlamydia.